Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Hodgkin Disease 7Carcinoma, Non-Small-Cell Lung 7Lymphoma 6Lung Neoplasms 6Recurrence 3Testicular Neoplasms 1Teratoma 1Pathologic Complete Response 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Mesothelioma, Malignant 1Lymphoma, Large-Cell, Anaplastic 1Kidney Neoplasms 1Glioma 1Carcinoma, Renal Cell 1Breast Neoplasms 1

Interventions

Cisplatin 4tremelimumab 3Pemetrexed 3durvalumab 2atezolizumab 2Radiotherapy 2Nivolumab 2Mitomycin 2Doxorubicin 2toripalimab 1talazoparib 1rucaparib 1regorafenib 1ranpirnase 1pembrolizumab 1niraparib 1liposomal doxorubicin 1dostarlimab 1cemiplimab 1bemcentinib 1avelumab 1abemaciclib 1Vinorelbine 1Vinblastine 1Thiostrepton 1Surgical Procedures, Operative 1Oxaliplatin 1One-Lung Ventilation 1Neoadjuvant Therapy 1Megestrol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Mesothelioma, Malignant × Vinblastine × Clear all
NCT00030459 2013-08-07

Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma

National Cancer Institute (NCI)

Phase 2 Unknown
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡